Divergent unprotected peptide macrocyclisation by palladium-mediated cysteine arylation
Name
c6sc05454d.pdf
Size
994.65 KB
Format
Adobe PDF
Checksum (MD5)
8a03a8f5c5bf50d0980a4cf29f52fd2f
Author(s)
Reilly, John
Rojas, Anthony Jose
Zhang, Chi
Vinogradova, Ekaterina V.
Buchwald, Nathan
Pentelute, Bradley L.
Buchwald, Stephen Leffler
Date Issued
December 2016
Journal
Chemical Science
Publisher
Royal Society of Chemistry (RSC)
Citation
Rojas, Anthony J. et al. “Divergent Unprotected Peptide Macrocyclisation by Palladium-Mediated Cysteine Arylation.” Chemical Science 8, 6 (2017): 4257–4263 © 2017 The Royal Society of Chemistry
Version
Final published version
Abstract
Macrocyclic peptides are important therapeutic candidates due to their improved physicochemical properties in comparison to their linear counterparts. Here we detail a method for a divergent macrocyclisation of unprotected peptides by crosslinking two cysteine residues with bis-palladium organometallic reagents. These synthetic intermediates are prepared in a single step from commercially available aryl bis-halides. Two bioactive linear peptides with cysteine residues at i, i + 4 and i, i + 7 positions, respectively, were cyclised to introduce a diverse array of aryl and bi-aryl linkers. These two series of macrocyclic peptides displayed similar linker-dependent lipophilicity, phospholipid affinity, and unique volume of distributions. Additionally, one of the bioactive peptides showed target binding affinity that was predominantly affected by the length of the linker. Collectively, this divergent strategy allowed rapid and convenient access to various aryl linkers, enabling the systematic evaluation of the effect of appending unit on the medicinal properties of macrocyclic peptides.
MIT Department
Massachusetts Institute of Technology. Department of Chemistry
Terms of Use
Creative Commons Attribution-NonCommercial 3.0 Unported
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1039/C6SC05454D
